What test is used to screen for hyperaldosteronism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Screening Test for Hyperaldosteronism

The aldosterone-to-renin ratio (ARR) is the screening test for hyperaldosteronism, measured from morning blood samples taken after the patient has been sitting for at least 15 minutes. 1, 2, 3

How to Perform the Screening Test

Sample Collection Requirements

  • Morning samples (more than 2 hours after awakening) 4
  • Sitting position after resting for 5-15 minutes 1, 5, 6, 2
  • Normal dietary salt intake
  • Correct hypokalemia before testing 7

Medication Management Before Testing

Continue most antihypertensives initially, but withhold these specific medications if possible 1, 5, 6, 2:

  • Aldosterone antagonists (spironolactone, eplerenone)
  • Angiotensin receptor blockers
  • Beta-adrenergic blockers
  • Clonidine

If withdrawal is unsafe, you can still proceed with testing, but interpret results cautiously. Beta-blockers may cause false positives when aldosterone is 10-15 ng/dL by immunoassay or 7.5-10 ng/dL by LC-MS/MS; above these levels, PA is likely despite beta-blocker use. 3

Interpreting the ARR

Positive Screening Criteria

ARR > 550 pmol/L/ng/mL/h (or 140 pmol/L/ng/L when using direct renin concentration) 1, 5, 6, 2

Critical caveat: Only calculate ARR if aldosterone is > 240 pmol/L (90 pg/mL) to avoid false positives from very low renin values 4. For very low renin values, use a floor value: PRA < 0.2 ng/mL/h should be calculated as 0.2, and direct renin < 5 mIU/L should be calculated as 5 4.

When Confirmatory Testing Can Be Skipped

You can bypass confirmatory testing and proceed directly to treatment in these specific situations 3, 7:

  1. Overt biochemical evidence: PRA < 0.2 ng/mL/h (or direct renin < 2 mU/L) AND aldosterone > 15 ng/dL by LC-MS/MS (or > 20 ng/dL by immunoassay) in patients with resistant hypertension or spontaneous hypokalemia 3

  2. Spontaneous hypokalemia with aldosterone > 20 ng/dL and suppressed renin 7

  3. Familial hyperaldosteronism confirmed by genetic testing 3

When Confirmatory Testing IS Needed

For patients with positive ARR but without the above criteria, proceed with one of these confirmatory tests 1, 5, 6, 2:

  1. Saline loading test: 2L normal saline over 4 hours; PA confirmed if aldosterone fails to suppress below 280 pmol/L
  2. Oral sodium loading: 300 mmol/day for 3 days; PA confirmed if aldosterone fails to suppress below 240 pmol/L
  3. Fludrocortisone suppression test: Oral sodium loading plus fludrocortisone 0.25 mg/day for 2 days; positive if aldosterone ≥ 140 pmol/L
  4. Captopril suppression test: PA confirmed if aldosterone fails to suppress below 240 pmol/L 2 hours after 25 mg oral captopril

Important pitfall: The first three tests risk inducing hypokalemia, fluid overload, and worsening hypertension 7. The captopril test is safer but may be less sensitive.

Special Populations

Chronic kidney disease: Expect higher false-positive rates because renin decreases with nephron loss and aldosterone can be elevated 3. Consider specialist referral for interpretation 8.

Borderline results: Repeat the initial test or perform a second confirmatory test. Patients negative on both saline infusion and captopril tests are unlikely to have unilateral disease 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.